Call Options

24 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $2.62 Million - $4.71 Million
-63,400 Reduced 73.72%
22,600 $954,000
Q1 2024

May 15, 2024

SELL
$56.27 - $73.77 $12.9 Million - $16.9 Million
-229,000 Reduced 72.7%
86,000 $5.94 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $1.49 Million - $1.92 Million
25,300 Added 8.73%
315,000 $23.3 Million
Q3 2023

Nov 14, 2023

BUY
$65.94 - $99.04 $7.41 Million - $11.1 Million
112,300 Added 63.3%
289,700 $19.8 Million
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $9.76 Million - $14.8 Million
155,700 Added 717.51%
177,400 $16.7 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $651,222 - $976,626
-13,800 Reduced 38.87%
21,700 $1.47 Million
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $1.45 Million - $2.54 Million
-47,700 Reduced 57.33%
35,500 $1.76 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $2.31 Million - $3.56 Million
72,200 Added 656.36%
83,200 $2.7 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $388,149 - $830,907
10,900 Added 10900.0%
11,000 $433,000
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $80,584 - $115,556
-1,400 Reduced 93.33%
100 $7,000
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $14,500 - $20,136
200 Added 15.38%
1,500 $117,000
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $18,048 - $24,810
200 Added 18.18%
1,300 $124,000
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $189,259 - $270,028
-1,900 Reduced 63.33%
1,100 $146,000
Q3 2020

Nov 13, 2020

SELL
$72.92 - $102.01 $2.99 Million - $4.18 Million
-41,000 Reduced 93.18%
3,000 $303,000
Q2 2020

Aug 14, 2020

BUY
$55.75 - $92.75 $2.37 Million - $3.94 Million
42,500 Added 2833.33%
44,000 $3.83 Million
Q1 2020

May 15, 2020

SELL
$37.9 - $104.44 $4.64 Million - $12.8 Million
-122,500 Reduced 98.79%
1,500 $87,000
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $1.5 Million - $1.92 Million
-19,300 Reduced 13.47%
124,000 $11.5 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $6.62 Million - $8.98 Million
73,300 Added 104.71%
143,300 $13 Million
Q2 2019

Aug 14, 2019

BUY
$89.51 - $118.04 $3.25 Million - $4.28 Million
36,300 Added 107.72%
70,000 $8.26 Million
Q4 2018

Feb 14, 2019

SELL
$56.04 - $82.66 $2.3 Million - $3.39 Million
-41,000 Reduced 54.89%
33,700 $2.13 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $1.79 Million - $2.98 Million
-37,000 Reduced 33.12%
74,700 $5.9 Million
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $3.26 Million - $6.02 Million
86,100 Added 336.33%
111,700 $6.68 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $2.19 Million - $3.17 Million
-55,100 Reduced 68.28%
25,600 $1.03 Million
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $3.75 Million - $4.88 Million
80,700
80,700 $4.24 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.91B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.